Fast, accurate detection and monitoring of health issues and comorbidities that may arise as part of COVID-19 disease are critical. Our comprehensive portfolio of systems and extensive menu in immunoassay, chemistry, hematology, hemostasis, molecular, and urinalysis, in conjunction with automation, informatics, and services, can help support the essential role of laboratory diagnostics.
We also offer labs a new high-throughput SARS-CoV-2 Antigen assay, now available on the Atellica® IM and ADVIA Centaur® XP/XPT Systems. Improve your confidence in SARS-CoV-2 mass screening with a high-throughput, central lab-based antigen assay that can quickly provide accurate results in at-risk individuals, including patients who are asymptomatic or in the early stage of the disease.